To put the current studies in perspective, TRPV1+ nociceptors potentiate adaptive immune responses in atopic dermatitis and psoriasis (Riol-Blanco et al. 2014; Wilson et al. 2013). This evidence concerns the gene TRPV1 and atopic eczema.